SCHEMBL31269404

SCHEMBL31269404

Cc1ccnc(Cn2c(-c3ccc(CC(=O)NC(C)C)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.34
▸ NFE2L2 Q16236 1/20 0.34
▸ PIK3CD O00329 5/20 0.34
▸ WNT3A P56704 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SCN5A Q14524 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ CNR1 P21554 2/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ MAPK10 P53779 2/20 0.31
▸ MAPK8 P45983 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ HIPK1 Q86Z02 1/20 0.31
▸ RIOK2 Q9BVS4 1/20 0.31
▸ SNRK Q9NRH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ AVPR1B P47901 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269369 0.92 PIK3CD (0.35) KEAP1NFE2L2PIK3CDWNT3AKCNH2
SCHEMBL31268860 0.91 TDP1 (0.33) KEAP1NFE2L2PIK3CDWNT3AKCNH2
SCHEMBL31268974 0.91 ALDH1A1 (0.35) PIK3CDKCNH2SCN5ASCN9ACNR1
SCHEMBL31269356 0.91 PIK3CD (0.35) PIK3CDWNT3AKCNH2SCN5ASCN9A
SCHEMBL31269318 0.90 PIK3CD (0.38) PIK3CDWNT3AKCNH2SCN5ASCN9A
SCHEMBL30984050 0.90 PIK3CD (0.36) PIK3CDWNT3AKCNH2SCN5ASCN9A
SCHEMBL31269126 0.90 PIK3CD (0.34) PIK3CDWNT3AKCNH2SCN5ASCN9A
SCHEMBL31268967 0.89 PIK3CD (0.33) PIK3CDWNT3AKCNH2SCN5ASCN9A
SCHEMBL31268793 0.89 PIK3CD (0.35) PIK3CDKCNH2SCN5ASCN9ACNR1
SCHEMBL30983484 0.89 PIK3CD (0.36) PIK3CDWNT3AKCNH2SCN5ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback